Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/09/681   
Active ingredient: 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide
Indication: Treatment of Huntington's disease
Sponsor: AOP Orphan Pharmaceuticals AG
Wilhelminenstraβe 91/IIf/B4, 1160 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2009 Orphan designation EMEA/OD/066/09 (2009)8519 of 28/10/2009
20/12/2017 Transfer of orphan designation EMA/OD/066/09/T/01 (2017)8998 of 18/12/2017